Financhill
Back

Intra-Cellular Therapies Stock Price Chart

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.

Intra-Cellular Therapies Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 77.18 Sell
20-day SMA: 73.66 Buy
50-day SMA: 70.03 Buy
200-day SMA: 65.86 Buy
8-day EMA: 75.77 Sell
20-day EMA: 74.05 Buy
50-day EMA: 71.71 Buy
200-day EMA: 66.9 Buy

Intra-Cellular Therapies Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.83 Buy
Relative Strength Index (14 RSI): 55.29 Buy
Chaikin Money Flow: -363676 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (69.38 - 76.96) Buy
Bollinger Bands (100): (65.78 - 73.44) Buy

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Intra-Cellular Therapies Stock

Is Intra-Cellular Therapies Stock a Buy?

ITCI Technical Analysis vs Fundamental Analysis

Sell
38
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy or a Sell?

Intra-Cellular Therapies Stock Info

Market Cap:
7.9B
Price in USD:
74.86
Share Volume:
685.07K

Intra-Cellular Therapies 52-Week Range

52-Week High:
84.89
52-Week Low:
45.50
Sell
38
Intra-Cellular Therapies (ITCI) is a Sell

Intra-Cellular Therapies Share Price Forecast

Is Intra-Cellular Therapies Stock a Buy?

Fundamental Analysis of Intra-Cellular Therapies

Is Intra-Cellular Therapies a good investment?

  • Analysts estimate an earnings increase this quarter of $0.44 per share, an increase next quarter of $0.09 per share, an increase this year of $1.09 per share, and an increase next year of $1.43 per share.

Technical Analysis of Intra-Cellular Therapies

Should I short Intra-Cellular Therapies stock?

* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.